Breaking News, Collaborations & Alliances

KKR, Flerie Form Specialized Pharma Services Platform with Investment in Coriolis Pharma

To extend Coriolis’ position in formulation development and analytical services for innovative high-value biologics, cell and gene therapy products.

KKR, a global investment firm, is joining forces with Flerie, to form a new global pharma services platform, Frontier Biosolutions, which will invest in a portfolio of companies focused on specialized pharmaceutical services to advanced therapeutics customers. Frontier will invest in differentiated scientific capabilities and proprietary technology platforms that address critical bottlenecks in the development and manufacturing of advanced therapeutics. Thomas Eldered will serve as Frontier’s...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters